NCT07032233 Assessment of Strength, Balance, and Function in Above-Knee Amputees in Relation to Residual Limb Length
| NCT ID | NCT07032233 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ceren Kuzu |
| Condition | Transfemoral Amputation |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-06-26 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15 participants in total. It began in 2025-06-26 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn how muscle strength, balance, and functional ability are affected in people with above-knee (transfemoral) amputations. The main questions it aims to answer are: How does the length of the lost part of the leg, compared to the intact leg, affect muscle strength, balance, and functional capacity? Is muscle strength at specific lower limb joints related to balance and performance ? Participants will: Have muscle strength measured at all intact lower limb joints using an isokinetic dynamometer Complete balance assessments using force platform technology that measures weight distribution and evaluates both static and dynamic balance Perform a six-minute walk test to evaluate endurance and functional capacity The study will help improve understanding of how limb length and joint-specific muscle strength impact mobility, supporting the development of better rehabilitation programs for amputees.
Eligibility Criteria
Inclusion Criteria: Individuals will be included in the study if they: Are between 18 and 50 years of age Are literate Have unilateral transfemoral amputation Have no cardiovascular, orthopedic, cognitive, or neurological conditions that could negatively affect balance, gait, or muscle strength Are able to ambulate independently with a prosthesis Have been walking for at least 6 months Voluntarily agree to participate in the study Exclusion Criteria: Participants will be excluded from the study if: They develop complications such as pain (rated 3 or higher on the Visual Analog Scale) or stump irritation during the course of the study Their residual limb length is less than 25 cm from the greater trochanter, which exceeds the limitations of the isokinetic dynamometer attachments used in the study They voluntarily withdraw from the study - in such cases, their data will be removed from the records
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07032233 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Transfemoral Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07032233 currently recruiting?
Yes, NCT07032233 is actively recruiting participants. Contact the research team at ce.kuzu@gmail.com for enrollment information.
Where is the NCT07032233 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07032233 clinical trial?
NCT07032233 is sponsored by Ceren Kuzu. The trial plans to enroll 15 participants.